ORAGENICS INC OGEN Cash Flow

Oragenics inc (OGEN)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Net loss
-17,428	-15,566	-14,724	-13,645	-11,120	-9,914	-8,619	-7,928	-6,868	-6,731	0	0	0	-	-	-	-12,481	-11,711	-10,715	-9,881	-5,441	-5,789	-7,645	-15,941	-16,119	-16,068	-14,978	-8,208	-13,063	-13,090	-13,040	-12,292	-7,736	-7,678	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion of discount on notes payable to shareholder
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	483	0	0	0	-	-	-	-
Depreciation and amortization
62	62	56	45	35	30	30	41	55	65	72	74	74	75	74	75	75	71	60	46	35	27	32	47	62	76	83	80	76	75	0	0	0	-	-	-	-
Depreciation and amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Stock-based compensation expense
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-	-	-	-	1,108	1,026	1,280	1,261	673	1,404	1,262	0	0	0
Stock issued as compensation to non-employee directors
-	-	-	-	-	-	-	-	-	123	181	161	162	151	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock-based compensation expense
-	-	-	-	-	-	-	436	437	437	409	528	441	487	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock issued in exchange for services
-	12	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	198	132	162	102	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Accounts receivable, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-13	-48	-32	-26	-12	-5	-13	10	-7	-22	28	-15	-32	-30	0	0	0
Income tax receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-362	0	0	0
Inventory, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	111	150	280	175	148	164	-296	-290	-245	-351	-185	-146	87	208	0	0	0
Prepaid expenses and other current assets
-1,650	-1,427	-1,377	-1,135	768	453	646	570	447	713	425	262	-172	-229	-160	-136	-156	-68	-208	-212	-178	-214	-164	-208	-213	-203	-166	-91	-48	-26	-66	-98	-157	-153	0	0	0
Accounts payable and accrued expenses
-188	498	528	203	863	225	757	1,460	993	525	808	367	175	446	156	268	645	348	253	-50	-298	-199	-259	-506	-261	-234	-233	5	-144	-57	91	130	440	225	0	0	0
Net cash used in operating activities
-14,625	-13,012	-12,054	-11,130	-9,923	-9,079	-7,460	-6,345	-5,830	-6,363	-6,969	-7,200	-7,355	-7,075	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-4,862	-5,203	-5,514	-5,494	0	0	0
Cash flows from investing activities:
Deferred revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-33	2	1	15	26	-32	-242	-62	-121	-101	104	-30	48	139	0	0	0
Net cash used in operating activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-5,263	-5,559	-5,597	-6,463	-6,767	-6,764	0	0	0	-	-	-	-	-	-	-	-
Purchase of property and equipment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	102	193	185	164	110	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from payment of note receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	750	0	0	0	-	-	-	-
Cash flows from financing activities:
Borrowings under convertible secured note payable to shareholder
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,500	0	0	0	-	-	-	-
Payments on short-term notes payable
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	140	0	0	0	-	-	-	-	-	-	-	-
Net proceeds from issuance of common stock and warrants
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-163	-110	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Payments on short-term notes payable
-	-	-	-	-	-	-	-170	-164	-157	-155	-155	-159	-158	-158	-158	-159	-159	-158	-158	-158	-158	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from payment of stock subscription receivable
-	-	-	-	-	-	-	-	-	30	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Borrowings under convertible secured note payable to shareholder
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Payments on short term notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	158	165	172	0	0	0
Restricted cash (receipts) released, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	61	144	195	268	203	238	245	94	210	0	0	0
Net cash provided by (used in) financing activities
-326	11,097	20,610	33,046	34,639	23,246	18,408	8,197	8,412	8,449	4,787	3,563	4,480	4,451	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	16,620	6,333	6,425	5,534	0	0	0
Net increase (decrease) in cash and cash equivalents
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-158	-158	9,115	13,025	13,094	13,133	0	0	0	-	-	-	-	-	-	-	-
Net increase in cash and cash equivalents
-	-	-	-	-	-	10,887	1,851	2,582	2,085	-2,181	-3,212	-1,200	-948	-1,631	-2,816	-5,708	-5,450	-5,058	-4,811	-5,585	-5,827	3,497	6,531	6,288	6,350	-3,489	5,237	7,382	9,754	11,757	1,130	911	39	0	0	0
Operating cash flows from discontinued operations
-	-	-	-	-	-	-	-	-	-	-	-	-	-54	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Supplemental disclosure of cash flow information:
Par value of common stock issued for cashless exercise of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-
Interest paid
7	7	6	6	2	5	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest paid
-	-	-	-	-	-	-	-	-	-	-	-	4	4	6	4	5	5	2	3	4	4	2	2	2	3	4	4	4	3	4	4	4	5	0	0	0
Non-cash investing and financing activities:
Borrowings under short term notes payable for prepaid expense
-	272	272	233	233	244	244	168	168	172	172	143	143	161	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock dividend on Series C preferred stock
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Short-term note receivable from stockholder in exchange for the issuance of common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Borrowings under short term notes payable for prepaid expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	157	157	158	158	50	157	157	157	241	134	134	0	0	0	-	-	-	-
Par value of restricted shares issued
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock dividend on Series C preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Par value of common stock issued in exchange for services
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Debt converted to Series C preferred stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11,275	0	0	0	-	-	-	-
Discount on note payable to shareholder for warrants issued
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	483	0	0	0	-	-	-	-
Fair market value of the 4,492,425 shares of common stock issued to Intrexon Corporation as a technology access fee
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Par value of forfeited stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	5.00	-	-	-	-
Series C Preferred Stock [Member]
Stock dividend on Series C preferred stock
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Series A Preferred Stock [Member]
Par value of common stock issued
-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Conversion of preferred stock into common stock
-	-	-	-	-	268	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-